Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration

Fenofibrate is a peroxisome proliferator-activated receptor α (PPARα) agonist and has been shown to have therapeutic effects on diabetic retinopathy (DR). However, the effects of fenofibrate through systemic administration are not as potent as desired due to inefficient drug delivery to the retina....

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Mol Pharm
Huvudupphovsmän: Qiu, Fangfang, Meng, Tuo, Chen, Qian, Zhou, Kelu, Shao, Yan, Matlock, Greg, Ma, Xiang, Wu, Wenjing, Du, Yanhong, Wang, Xiang, Deng, Guotao, Ma, Jian-xing, Xu, Qingguo
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2019
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6502649/
https://ncbi.nlm.nih.gov/pubmed/30912953
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/acs.molpharmaceut.8b01319
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk